DE60233601D1 - Verwendung von bestimmten Cyclolignanen - Google Patents

Verwendung von bestimmten Cyclolignanen

Info

Publication number
DE60233601D1
DE60233601D1 DE60233601T DE60233601T DE60233601D1 DE 60233601 D1 DE60233601 D1 DE 60233601D1 DE 60233601 T DE60233601 T DE 60233601T DE 60233601 T DE60233601 T DE 60233601T DE 60233601 D1 DE60233601 D1 DE 60233601D1
Authority
DE
Germany
Prior art keywords
cyclolignans
certain
certain cyclolignans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233601T
Other languages
German (de)
English (en)
Inventor
Olle Larsson
Magnus Axelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axelar AB
Original Assignee
Axelar AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0102168A external-priority patent/SE0102168D0/xx
Application filed by Axelar AB filed Critical Axelar AB
Application granted granted Critical
Publication of DE60233601D1 publication Critical patent/DE60233601D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60233601T 2001-06-19 2002-06-19 Verwendung von bestimmten Cyclolignanen Expired - Lifetime DE60233601D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102168A SE0102168D0 (sv) 2001-06-19 2001-06-19 New use and new compounds
US30043101P 2001-06-26 2001-06-26

Publications (1)

Publication Number Publication Date
DE60233601D1 true DE60233601D1 (de) 2009-10-15

Family

ID=26655492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233601T Expired - Lifetime DE60233601D1 (de) 2001-06-19 2002-06-19 Verwendung von bestimmten Cyclolignanen

Country Status (5)

Country Link
JP (1) JP2009242406A (no)
KR (1) KR20040030686A (no)
AU (2) AU2009201542B2 (no)
DE (1) DE60233601D1 (no)
NO (1) NO20035647L (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100971364B1 (ko) * 2009-12-28 2010-07-20 명 하 윤 굴삭기 그라브 실린더의 유압 분배용 어댑터

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585936B2 (en) * 1984-12-28 1989-06-29 Conpharm A.B. Pharmaceutically active podophyllotoxins
JPH09194368A (ja) * 1996-01-11 1997-07-29 Pola Chem Ind Inc ポドフィロトキシン誘導体及びそれからなる新規細胞分化誘導剤

Also Published As

Publication number Publication date
JP2009242406A (ja) 2009-10-22
KR20040030686A (ko) 2004-04-09
NO20035647L (no) 2004-02-18
AU2009201542A1 (en) 2009-05-14
AU2010200488A1 (en) 2010-03-04
AU2009201542B2 (en) 2011-06-23
NO20035647D0 (no) 2003-12-17

Similar Documents

Publication Publication Date Title
DE50212455D1 (de) Verwendung von Dimerdiolen
DE60221977D1 (de) Pro-pharmakon von cox-2-inhibitoren
DE60236226D1 (de) Verbesserung der Altersweitsichtigkeit
DE60217432D1 (de) Verwendungen von Kohlenstofffasern
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DE60211601D1 (de) Bereitstellung von positionsabhängigen Inhalten
ATE510556T1 (de) Verwendung von erythropoietin
DE02784674T1 (de) Quantifizierung von polypeptiden
DE60204093D1 (de) Substanzgemisch von Triphenylamindimeren
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
ITMI20021038A0 (it) Disposizione di elettrodi
NO20041968L (no) Anvendelse av cystationin
ATE275390T1 (de) Verwendung von kationischen zubereitungen
DE60227828D1 (de) E von schmelzkleber
DE60318819D1 (de) Hitzestabile mutanten von stärkebiosyntheseenzymen
DE50311406D1 (de) Verwendung von Formkörpern
ATE556564T1 (de) Zuweisung von zeitschlitzen
ATE395917T1 (de) Kombination von docetaxel mit flavopiridol
DE60007360T2 (de) Amorphe modifikation von torasemid
ATE272388T1 (de) Verwendung von kationischen zubereitungen
DE60330315D1 (de) Acylfluorid-aktivierung von mit carboxysilyl beschichteten glassubstraten
DE60233601D1 (de) Verwendung von bestimmten Cyclolignanen
DE50205590D1 (de) Ummantelung von leiterbahnen
DE50203046D1 (de) Verwendung von Esterquats
ATE348606T1 (de) Neue verwendung von pipatalin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition